文献速递冠心病

左主干病变依维莫司洗脱支架与搭桥术后的生活质量:EXCEL试验结果

Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial.
PubMed 文献 · J Am Coll Cardiol · 2017-10-30

EXCEL试验的生活质量亚组前瞻性纳入1788例无保护左主干患者,随机接受CABG或依维莫司洗脱支架PCI,用SAQ、SF-12、Rose呼吸困难量表、PHQ-8和EQ-5D在基线及1、12、36个月评估。36个月内两种血运重建均显著改善生活质量;PCI在1个月时优于CABG,12个月时差异大部分减弱,36个月时无显著差异。

要点

  • 左主干患者PCI与CABG均显著改善36个月生活质量。
  • PCI在1个月时生活质量优于CABG,早期获益更明显。
  • 36个月时两种策略生活质量无显著差异。

核心结论

  • 在选择的左主干患者中,PCI与CABG至36个月带来相似的生活质量改善,但PCI早期获益更大。

研究设计与样本

  • EXCEL试验的前瞻性生活质量亚组,2010年9月至2014年3月随机1905例左主干患者,其中1788例参与生活质量亚组。
  • 生活质量在基线及1、12、36个月用SAQ、SF-12、Rose呼吸困难量表、PHQ-8和EQ-5D评估,采用纵向随机效应增长曲线模型比较PCI与CABG差异。

主要发现

  • 36个月内PCI和CABG均较基线显著改善生活质量。
  • 1个月时PCI与更好的生活质量相关。
  • 12个月时差异大部分减弱,36个月时PCI与CABG无显著生活质量差异。

临床怎么用

  • 对选择的左主干患者,可将生活质量改善作为与患者共同决策时PCI与CABG疗效相似至36个月的参考信息。
  • 需向患者说明PCI可能带来早期生活质量优势,但中期差异消失。

局限性

  • 生活质量亚组仅纳入1905例随机患者中的1788例,可能影响代表性。
  • 原文未报告具体生活质量评分变化值、置信区间或P值。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The EXCEL (Evaluation of Xience Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial compared outcomes in patients with unprotected left main coronary artery disease (LMCAD) treated with coronary artery bypass graft (CABG) or percutaneous coronary intervention (PCI) using everolimus-eluting stents. Whereas rates of death, stroke, and myocardial infarction were similar at 36 months, event timing and repeat revascularization rates differed by treatment group. OBJECTIVES: To understand the effects of revascularization strategy from the patient's perspective, a prospective quality of life (QoL) substudy was performed alongside the EXCEL trial. METHODS: Between September 2010 and March 2014, 1,905 patients with LMCAD were randomized to undergo CABG or PCI, of whom 1,788 participated in the QoL substudy. QoL was assessed at baseline and 1, 12, and 36 months using the Seattle Angina Questionnaire, the 12-Item Short Form Health Survey, the Rose Dyspnea Scale, the Patient Health Questionnaire-8, and the EQ-5D. Differences between PCI and CABG were assessed using longitudinal random-effect growth curve models. RESULTS: Over 36 months, both PCI and CABG were associated with significant improvements in QoL compared with baseline. At 1 month, PCI was associated with better QoL than CABG. By 12 months though, these differences were largely attenuated, and by 36 months, there were no significant QoL differences between PCI and CABG. CONCLUSIONS: Among selected patients with LMCAD, both PCI and CABG result in similar QoL improvement through 36 months, although a greater early benefit is seen with PCI. Taken together with the 3-year clinical results of EXCEL, these findings suggest that PCI and CABG provide similar intermediate-term outcomes for patients with LMCAD. (Evaluation of Xience Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization [EXCEL]; NCT01205776).

来源:J Am Coll Cardiol,查看原文。版权归原作者所有。

引用

  1. Baron SJ, Chinnakondepalli K, Magnuson EA, et al. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial. J Am Coll Cardiol. 2017. PMID: 29097293. doi:10.1016/j.jacc.2017.10.036

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。